Join a Trial!

Participate Today
Save Lives Tomorrow!

Learn More

Featured Study

MASH Trial

 

FOMAT is currently enrolling participants for a MASH clinical trial.

Metabolic-associated steatohepatitis (MASH), previously known as non-alcoholic steatohepatitis (NASH), is a silent condition that often remains symptomless until it reaches advanced stages. This disease involves the accumulation of excess fat in the liver, which over time leads to inflammation and liver damage. In its early stages, MASH may go unnoticed, but as it progresses, it can develop into cirrhosis, significantly impairing liver function and increasing the risk of severe complications. Early detection and intervention are crucial to halting the progression of MASH and safeguarding liver health.

Ask Us for More Info

Which Clinical Trial Do You Want To Participate In?

Active Studies

Filter Trials By Status

Filter Trials By Location

Filter Trials By Age

Filter Trials by Condition

  • Santa Maria

    Ulcerative Colitis

    Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.

    Criteria & Qualifications: • Is at least 18 years of age or older.
    • Diagnosed with Ulcerative colitis in the last 3 months.
    • Is willing to provide medical records.
    • Must have active symptoms, such as rectal bleeding.

    Compensation: up to $1,500

    Read more
  • Arcadia, Glendora, Monrovia, Pasadena

    Crohn’s Disease Study

    Crohn’s disease is a chronic inflammatory condition that impacts the digestive tract. This clinical trial is focused on exploring new treatment options to improve the health and quality of life for those living with Crohn’s disease.

    Criteria & Qualifications: • Is at least 18 years of age or older.
    • Diagnosis of Crohn's disease (CD) for at least 3 months.
    • Is willing to provide medical records.

    Compensation: Contact us for more information

    Read more
  • Santa Maria

    NASH/MASH Study

    Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH.

    Criteria & Qualifications:  • Is at least 18 years of age or older.
    • Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
    • Must be weight stable for 6 months.

    Compensation: Up to $3,000.

    Read more

Participate Today
Save Lives Tomorrow!

Join a Trial!

Be part of Advancing Research! ​


    What Are Clinical Trials And Are They Safe?

    Learn More
    What are Clinical Trials